The up-regulation of PAK2 indicates unfavorable prognosis in patients with serous epithelial ovarian cancer and contributes to paclitaxel resistance in ovarian cancer cells.

BMC Cancer · 2024 · PMC11440729 · PMID 39350056

Europe PMC DOI

hedged sentence

0.0002

closest p · 0.0× alpha

0.0002

boldest claim

The sentences

highly significantP = 0.00021actually significant

The findings demonstrate significant variances between stage I and II ( P = 0.027), highly significant variances between stage I and III ( P = 0.00021), and extremely significant variances between stage I and IV ( P = 0.0054).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.